⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ether SCHEMBL15532530 | 0.90 | ALDH1A1 (0.32) | — | |
| Ethyl Hydrogen Phosphonate SCHEMBL28364580 | 0.83 | — | — | |
| Ethyl Hydrogen Phosphonate SCHEMBL29833476 | 0.80 | ALDH1A1 (0.35) | — | |
| Ethyl Hydrogen Phosphonate SCHEMBL28925 | 0.80 | — | — | |
| SCHEMBL6153658 | 0.78 | — | — | |
| Ethyl Hydrogen Phosphonate SCHEMBL7193350 | 0.77 | — | — | |
| Ethyl Hydrogen Phosphonate SCHEMBL5449338 | 0.77 | — | — | |
| Ethyl Hydrogen Phosphonate SCHEMBL7183165 | 0.77 | — | — | |
| Ethyl Hydrogen Phosphonate SCHEMBL21178179 | 0.77 | — | — | |
| Ethyl Hydrogen Phosphonate SCHEMBL676703 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11613618-B2 | Porous body, and method for producing porous body | EMAUS KYOTO, INC. (JP) | 2023-03-28 | — | — | US | disclosed |
| US-20210214514-A1 | POROUS BODY, AND METHOD FOR PRODUCING POROUS BODY | EMAUS KYOTO, INC. (JP) | 2021-07-15 | — | — | US | disclosed |
| EP-3789444-A1 | POROUS BODY, AND METHOD FOR PRODUCING POROUS BODY | Emaus Kyoto, Inc. (JP) | 2021-03-10 | — | — | EP | disclosed |
| US-10858491-B2 | Porous particle made of organic polymer, method for producing porous particle made of organic polymer, and block copolymer | KYOTO UNIVERSITY (JP) | 2020-12-08 | — | — | US | disclosed |
| EP-3327071-B1 | POROUS PARTICLE MADE OF ORGANIC POLYMER, METHOD FOR PRODUCING POROUS PARTICLE MADE OF ORGANIC POLYMER | UNIV KYOTO (JP) | 2020-04-29 | — | — | EP | disclosed |
| US-20180223067-A1 | POROUS PARTICLE, METHOD FOR PRODUCING POROUS PARTICLE, AND BLOCK COPOLYMER | KYOTO UNIVERSITY (JP) | 2018-08-09 | — | — | US | disclosed |
| EP-3327071-A1 | POROUS PARTICLE MADE OF ORGANIC POLYMER, METHOD FOR PRODUCING POROUS PARTICLE MADE OF ORGANIC POLYMER, AND BLOCK COPOLYMER | Kyoto University (JP) | 2018-05-30 | — | — | EP | disclosed |
| EP-3327070-A1 | POROUS PARTICLE, METHOD FOR PRODUCING POROUS PARTICLE, AND BLOCK COPOLYMER | Kyoto University (JP) | 2018-05-30 | — | — | EP | disclosed |
| US-20050182040-A1 | Benzamide derivatives | DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) | 2005-08-18 | — | — | US | disclosed |
| EP-1500643-A1 | BENZAMIDE DERIVATIVES | SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) | 2005-01-26 | — | — | EP | disclosed |
| US-20030018056-A1 | Substituted guanidine derivatives | SUMITOMO PHARMACEUTICALS COMPANY LIMITED (JP) | 2003-01-23 | — | — | US | disclosed |
| EP-1238971-A1 | SUBSTITUTED GUANIDINE DERIVATIVES | SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) | 2002-09-11 | — | — | EP | disclosed |
| US-20010053779-A1 | Novel compounds and compositions for treating diseases asociated with protease activity | Celera Corporation | 2001-12-20 | — | — | US | disclosed |
| US-6150379-A | BLOOD COAGULATION FACTOR XA INHIBITORS; TREATING DISEASES ASSOCIATED WITH SERINE PROTEASE ACTIVITY; THROMBOLYTIC AND ISCHEMIC AGENTS; E.G., 2-(6-(5-AMIDINO-1H-BENZIMIDAZOL-2-YL)-PYRID-3-YLCARBONYLAMINO)-3 -HYDROXYBUTYRIC ACID | AXYS PHARMACEUTICALS, INC. (US) | 2000-11-21 | — | — | US | disclosed |
| EP-1019382-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING DISEASES ASSOCIATED WITH SERINE PROTEASE, PARTICULARLY TRYPTASE, ACTIVITY | AXYS PHARMACEUTICALS, INC. (US) | 2000-07-19 | — | — | EP | disclosed |
| WO-1999026932-A1 | BY AMIDINO GROUP SUBSTITUTED HETEROCYCLIC DERIVATIVES AND THEIR USE AS ANTICOAGULANTS | AXYS PHARMACEUTICALS, INC. (US) | 1999-06-03 | — | — | WO | disclosed |
| WO-1999026941-A1 | SUBSTITUTED AMIDINOARYL DERIVATIVES AND THEIR USE AS ANTICOAGULANTS | AXYS PHARMACEUTICALS, INC. (US) | 1999-06-03 | — | — | WO | disclosed |
| WO-1999026933-A1 | SUBSTITUTED AMIDINOARYL DERIVATIVES AND THEIR USE AS ANTICOAGULANTS | AXYS PHARMACEUTICALS, INC. (US) | 1999-06-03 | — | — | WO | disclosed |
| WO-1998045275-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING DISEASES ASSOCIATED WITH SERINE PROTEASE, PARTICULARLY TRYPTASE, ACTIVITY | AXYS PHARMACEUTICALS CORPORATION (US) | 1998-10-15 | — | — | WO | disclosed |
| US-4927841-A | Fungicidal imidazole oxime derivatives | SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ, B.V. (NL) | 1990-05-22 | — | — | US | disclosed |